Dr Fran Gregory Discusses the Impact of the New Wave of Biosimilars on Rebate Practices
Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health, discusses the role the new wave of biosimilars will have on rebate practices for both pharmacy benefit managers (PBMs) and payers.